A significant breakthrough in cancer investigation is occurring with the use of nanobodies to reactivate dysfunctional p53. This vital malignant protector protein is frequently inactivated in various forms of https://sociallawy.com/story12575410/mini-antibodies-reactivate-tumor-suppressor-p53-a-new-approach-for-malignant-treatment